Prohost Letter #402

Prohost Letter #402
Antisense Proof of Concept and Feasibility

EYE ON INVIVA (INVA)

Sales of The Ellipta Inhalers Started to Pick up

AND ON THERAVANCE BIOPHARMA (TBPH)

See Below

AND WE WILL NOT LOSE FOCUS ON

ARIAD (ARIA), EXELIXIS (EXEL), ARRAY (ARRY), PORTOLA (PTLA), NEKTAR (NKTR), THERAVANCE BIOPHARMA (TBPH), INVIVA (INVA), MERCK (MRK) AND

SEE THE TABLES

IONIS (IONS)

The . . .

This content is for paid subscribers.
Please click here to subscribe or here to log in.